Y
Yuzo Watanabe
Researcher at Nagoya University
Publications - 75
Citations - 1941
Yuzo Watanabe is an academic researcher from Nagoya University. The author has contributed to research in topics: Dialysis & Hemodialysis. The author has an hindex of 20, co-authored 71 publications receiving 1770 citations. Previous affiliations of Yuzo Watanabe include Osaka City University & University of Chicago.
Papers
More filters
Journal ArticleDOI
Overview of Regular Dialysis Treatment in Japan (as of 31 December 2011)
Shigeru Nakai,Yuzo Watanabe,Ikuto Masakane,Atsushi Wada,Tetsuo Shoji,Takeshi Hasegawa,Hidetomo Nakamoto,Kunihiro Yamagata,Junichiro James Kazama,Naohiko Fujii,Noritomo Itami,Toshio Shinoda,Takashi Shigematsu,Seiji Marubayashi,Osamu Morita,Seiji Hashimoto,Kazuyuki Suzuki,Naoki Kimata,Norio Hanafusa,Kenji Wakai,Takayuki Hamano,Satoshi Ogata,Kenji Tsuchida,Masatomo Taniguchi,Hiroshi Nishi,Kunitoshi Iseki,Yoshiharu Tsubakihara +26 more
TL;DR: A nationwide statistical survey of 4255 dialysis facilities was conducted at the end of 2011 and the results included questions related to the Great East Japan Earthquake, which occurred on 11 March 2011.
Journal ArticleDOI
Overview of regular dialysis treatment in Japan (as of 31 December 2008).
Shigeru Nakai,Kazuyuki Suzuki,Ikuto Masakane,Atsushi Wada,Noritomo Itami,Satoshi Ogata,Naoki Kimata,Takashi Shigematsu,Toshio Shinoda,Tetsuo Syouji,Masatomo Taniguchi,Kenji Tsuchida,Hidetomo Nakamoto,Shinichi Nishi,Hiroshi Nishi,Seiji Hashimoto,Takeshi Hasegawa,Norio Hanafusa,Takayuki Hamano,Naohiko Fujii,Seiji Marubayashi,Osamu Morita,Kunihiro Yamagata,Kenji Wakai,Yuzo Watanabe,Kunitoshi Iseki,Yoshiharu Tsubakihara +26 more
TL;DR: The risk of becoming HCV‐positive was high in patients with low serum creatinine, serum albumin, and serum total cholesterol levels, and/or a low body mass index before beginning dialysis, and the percentage is particularly high in Patients with a period of dialysis of 20 years or longer.
Journal ArticleDOI
An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2010)
Shigeru Nakai,Kunitoshi Iseki,Noritomo Itami,Satoshi Ogata,Junichiro James Kazama,Naoki Kimata,Takashi Shigematsu,Toshio Shinoda,Tetsuo Shoji,Kazuyuki Suzuki,Masatomo Taniguchi,Kenji Tsuchida,Hidetomo Nakamoto,Hiroshi Nishi,Seiji Hashimoto,Takeshi Hasegawa,Norio Hanafusa,Takayuki Hamano,Naohiko Fujii,Ikuto Masakane,Seiji Marubayashi,Osamu Morita,Kunihiro Yamagata,Kenji Wakai,Atsushi Wada,Yuzo Watanabe,Yoshiharu Tsubakihara +26 more
TL;DR: A nationwide statistical survey of 4226 dialysis facilities was conducted at the end of 2010, and 4166 facilities responded, and the number of new patients introduced into dialysis was 37 512, which has decreased for two consecutive years since it peaked in 2008.
Journal ArticleDOI
An overview of regular dialysis treatment in Japan (as of 31 December 2012).
Shigeru Nakai,Norio Hanafusa,Ikuto Masakane,Masatomo Taniguchi,Takayuki Hamano,Tetsuo Shoji,Takeshi Hasegawa,Noritomo Itami,Kunihiro Yamagata,Toshio Shinoda,Junichiro James Kazama,Yuzo Watanabe,Takashi Shigematsu,Seiji Marubayashi,Osamu Morita,Atsushi Wada,Seiji Hashimoto,Kazuyuki Suzuki,Hidetomo Nakamoto,Naoki Kimata,Kenji Wakai,Naohiko Fujii,Satoshi Ogata,Kenji Tsuchida,Hiroshi Nishi,Kunitoshi Iseki,Yoshiharu Tsubakihara +26 more
TL;DR: The dialysis patient population has been growing every year in Japan; it was 310 007 at the end of 2012, which exceeded 310’000 for the first time, and the percentage of dialysis patients with diabetic nephropathy has been continuously increasing, whereas not only the percentage but also the actual number of dial renal failure patients with chronic glomerulonephritis has decreased.
Journal ArticleDOI
Elevated Non-high-density Lipoprotein Cholesterol (Non-HDL-C) Predicts Atherosclerotic Cardiovascular Events in Hemodialysis Patients
TL;DR: Dyslipidemia was associated with increased risk of incident atherosclerotic CVD, and protein energy wasting/inflammation with increasedrisk of death after CVD events in this hemodialysis cohort.